查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602374

光化性角化症治療市場：按疾病類型、治療方法、最終用戶分類 - 全球預測 2025-2030

Actinic Keratosis Treatment Market by Disease Type (Clinical AK, Subclinical AK), Treatment (Medication, Surgery), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

光化性角化症治療市場2023年估值為62.1億美元，預計2024年將達64.8億美元，複合年成長率為4.37%，2030年將達83.8億美元，預計將達到1000萬美元。

光化性角化症 (AK) 是一種常見的皮膚病，其特徵是長期陽光照射導致的粗糙、鱗狀斑塊，並且通常被視為癌症，因為它可以發展成鱗狀細胞癌。市面上有多種治療 AK 的治療方法，包括局部藥物、動態、光動力療法和手術。這些治療的需求是由於人們對皮膚癌預防意識的增強以及生活方式和衰老導致 AK 盛行率的增加。主要應用領域包括皮膚科診所、醫院和專業護膚中心，最終用戶範圍從尋求預防保健的個人到已經出現症狀的人。

主要市場統計
基準年[2023] 62.1億美元
預測年份 [2024] 64.8億美元
預測年份 [2030] 83.8億美元
複合年成長率（%） 4.37%

市場成長受到配方進步、醫療成本增加以及公眾對未經治療的 AK 危險性認知的提高等因素的影響。另一方面，在快速成長的亞太和拉丁美洲，醫療資源的改善正在推動需求，市場擴張的機會正在擴大。抓住這些機會的治療方法包括對遠距皮膚科服務和家庭治療系統的投資，這與遠距醫療解決方案的成長趨勢一致。

儘管有這些有希望的成長途徑，但挑戰仍然存在，包括與先進治療方法相關的高成本、報銷問題以及與現有治療方法相關的潛在副作用。此外，嚴格的法規環境和已開發市場的飽和可能會阻礙快速擴張。為了克服這些限制，非侵入性技術和聯合治療的創新具有巨大的潛力。此外，對 AK 的遺傳和分子方面的研究可能會提供新的見解，並為標靶治療鋪平道路。

總體而言，AK 療法市場是一個充滿活力的市場，由於技術進步和健康意識的提高，該市場有望實現強勁成長。企業必須策略性地應對這些機會和挑戰，並專注於創新和策略夥伴關係，以推動市場滲透並改善消費者成果。

市場動態：快速發展的光化性角化病治療市場的關鍵市場洞察

光化性角化症治療市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 光化性角化症和皮膚癌患者數量增加
    • 戶外運動偏好的興起與發展
    • 提高消費者對皮膚病的認知
  • 市場限制因素
    • 與光化性角化症治療相關的不良健康影響
  • 市場機會
    • 外用皮膚製劑和動態角化病治療的核准迅速增加
    • 光動力動態治療光化性角化症和非黑色素瘤皮膚癌的進展
  • 市場挑戰
    • 光化性角化症治療缺乏標準化

波特的五力：駕馭光化性角化症治療市場的策略工具

波特的五力架構是了解光化性角化症治療市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解光化性角化症治療市場的外部影響

外部宏觀環境因素在塑造光化性角化病治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解光化性角化症治療市場的競爭狀況

光化性角化症治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣光化性角化症治療市場供應商的績效評估

FPNV定位矩陣是評估光化性角化病治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製光化性角化病治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對光化性角化病治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 光化性角化症和皮膚癌的病例正在增加
      • 戶外運動活動的日益偏好與發展
      • 提高消費者對皮膚病的認知
    • 抑制因素
      • 與光化性角化症治療相關的不良健康影響
    • 機會
      • 光化性角化症的外用製劑和治療藥物的核准激增
      • 光動力動態在光化性角化症和非黑色素瘤皮膚癌治療的持續進展
    • 任務
      • 光化性角化症治療缺乏標準化
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章光化性角化症治療市場：依疾病類型

  • 臨床AK
  • 潛在AK

第7章光化性角化症治療市場（依治療）

  • 藥物治療
    • 藥膏或凝膠
      • Fluorouracil
      • 咪喹莫特
      • 巨大戟二甲酚甲丁酸酯或雙氯芬酸鈉
  • 外科手術
    • 冷凍療法
    • 刮宮術
    • 雷射治療
    • 動態療法

第8章光化性角化症治療市場：依最終用戶分類

  • 癌症治療中心
  • 居家護理
  • 醫院
  • 雷射治療中心
  • 私人皮膚科診所
  • 水療和恢復中心

第9章北美及南美光化性角化症治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區光化性角化症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的光化性角化病治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Accord Healthcare, Inc.
  • AdipoGen Life Sciences
  • Almirall, SA
  • Athenex, Inc.
  • Bausch Health Companies, Inc.
  • Biofrontera AG
  • Enzo Life Sciences Inc.
  • Fresenius Kabi
  • Galderma SA
  • Glenmark Pharmaceuticals Limited
  • Hill Dermaceuticals, Inc.
  • LEO Pharma A/S.
  • Merck KGaA
  • Novartis AG
  • Perrigo Company PLC
  • Sagent Pharmaceuticals, Inc.
  • Spear Dermatology Products, Inc.
  • Stanford Chemicals Company
  • Strides Pharma Science Limited
  • Sun Pharmaceutical Industries Ltd.
  • Taj Pharmaceuticals Ltd.
  • Taro Pharmaceutical Industries Ltd.
  • Viatris, Inc.
  • Xiromed LLC
Product Code: MRR-B16853776CEB

The Actinic Keratosis Treatment Market was valued at USD 6.21 billion in 2023, expected to reach USD 6.48 billion in 2024, and is projected to grow at a CAGR of 4.37%, to USD 8.38 billion by 2030.

Actinic Keratosis (AK) is a common skin condition characterized by rough, scaly patches caused by prolonged sun exposure, often considered precancerous due to their potential to develop into squamous cell carcinoma. The treatment market for AK encompasses a range of therapies, including topical medications, cryotherapy, photodynamic therapy, and surgical procedures. The necessity for these treatments stems from the growing awareness of skin cancer prevention and the increasing prevalence of AK due to lifestyle factors and an aging population. Key application sectors include dermatology clinics, hospitals, and specialty skincare centers, with end-users spanning individuals seeking preventative care to those already exhibiting symptoms.

KEY MARKET STATISTICS
Base Year [2023] USD 6.21 billion
Estimated Year [2024] USD 6.48 billion
Forecast Year [2030] USD 8.38 billion
CAGR (%) 4.37%

Market growth is influenced by factors such as advancements in pharmaceutical formulations, increasing healthcare expenditures, and heightened public awareness regarding the dangers of untreated AK. Meanwhile, opportunities for expansion are evident in the burgeoning markets of Asia-Pacific and Latin America, where increased access to healthcare resources is driving demand. Recommendations to seize these opportunities include investment in teledermatology services and home-based treatment systems, which cater to the growing trend of remote healthcare solutions.

Despite these promising growth avenues, challenges persist, including the high costs associated with advanced treatment modalities, reimbursement issues, and the potential side effects linked to existing therapeutic options. Furthermore, stringent regulatory environments and market saturation in developed regions may impede rapid expansion. To overcome these limitations, innovation in non-invasive technologies and combination therapies holds significant potential. Research into genetic and molecular aspects of AK can also yield novel insights, paving the way for targeted therapies.

Overall, the AK treatment market presents a dynamic landscape with robust growth prospects driven by technological advancements and rising health consciousness. Businesses must strategically navigate these opportunities and challenges, focusing on innovation and strategic partnerships to foster market penetration and enhance consumer outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Actinic Keratosis Treatment Market

The Actinic Keratosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of cases of actinic keratosis and skin cancer
    • Growing preference and development of outdoor sports activities
    • Accelerated awareness among consumers for dermatological disease
  • Market Restraints
    • Associated adverse health impacts of actinic keratosis treatment
  • Market Opportunities
    • Surge in approvals of topical agents and treatment for actinic keratosis
    • Ongoing advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer
  • Market Challenges
    • Lack of standardizations for actinic keratosis treatment

Porter's Five Forces: A Strategic Tool for Navigating the Actinic Keratosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Actinic Keratosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Actinic Keratosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Actinic Keratosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Actinic Keratosis Treatment Market

A detailed market share analysis in the Actinic Keratosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Actinic Keratosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Actinic Keratosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Actinic Keratosis Treatment Market

A strategic analysis of the Actinic Keratosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Actinic Keratosis Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Accord Healthcare, Inc., AdipoGen Life Sciences, Almirall, S.A., Athenex, Inc., Bausch Health Companies, Inc., Biofrontera AG, Enzo Life Sciences Inc., Fresenius Kabi, Galderma SA, Glenmark Pharmaceuticals Limited, Hill Dermaceuticals, Inc., LEO Pharma A/S., Merck KGaA, Novartis AG, Perrigo Company PLC, Sagent Pharmaceuticals, Inc., Spear Dermatology Products, Inc., Stanford Chemicals Company, Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Viatris, Inc., and Xiromed LLC.

Market Segmentation & Coverage

This research report categorizes the Actinic Keratosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Clinical AK and Subclinical AK.
  • Based on Treatment, market is studied across Medication and Surgery. The Medication is further studied across Medicated Cream or Gel. The Medicated Cream or Gel is further studied across Fluorouracil, Imiquimod, and Ingenol Mebutate or Diclofenac. The Surgery is further studied across Cryotherapy, Curettage, Laser Therapy, and Photodynamic Therapy.
  • Based on End-User, market is studied across Cancer Treatment Centers, Homecare, Hospitals, Laser Therapy Centers, Private Dermatology Clinics, and Spas & Rejuvenation Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cases of actinic keratosis and skin cancer
      • 5.1.1.2. Growing preference and development of outdoor sports activities
      • 5.1.1.3. Accelerated awareness among consumers for dermatological disease
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse health impacts of actinic keratosis treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals of topical agents and treatment for actinic keratosis
      • 5.1.3.2. Ongoing advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardizations for actinic keratosis treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Actinic Keratosis Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Clinical AK
  • 6.3. Subclinical AK

7. Actinic Keratosis Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medication
    • 7.2.1. Medicated Cream or Gel
      • 7.2.1.1. Fluorouracil
      • 7.2.1.2. Imiquimod
      • 7.2.1.3. Ingenol Mebutate or Diclofenac
  • 7.3. Surgery
    • 7.3.1. Cryotherapy
    • 7.3.2. Curettage
    • 7.3.3. Laser Therapy
    • 7.3.4. Photodynamic Therapy

8. Actinic Keratosis Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Cancer Treatment Centers
  • 8.3. Homecare
  • 8.4. Hospitals
  • 8.5. Laser Therapy Centers
  • 8.6. Private Dermatology Clinics
  • 8.7. Spas & Rejuvenation Centers

9. Americas Actinic Keratosis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Actinic Keratosis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Actinic Keratosis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Accord Healthcare, Inc.
  • 3. AdipoGen Life Sciences
  • 4. Almirall, S.A.
  • 5. Athenex, Inc.
  • 6. Bausch Health Companies, Inc.
  • 7. Biofrontera AG
  • 8. Enzo Life Sciences Inc.
  • 9. Fresenius Kabi
  • 10. Galderma SA
  • 11. Glenmark Pharmaceuticals Limited
  • 12. Hill Dermaceuticals, Inc.
  • 13. LEO Pharma A/S.
  • 14. Merck KGaA
  • 15. Novartis AG
  • 16. Perrigo Company PLC
  • 17. Sagent Pharmaceuticals, Inc.
  • 18. Spear Dermatology Products, Inc.
  • 19. Stanford Chemicals Company
  • 20. Strides Pharma Science Limited
  • 21. Sun Pharmaceutical Industries Ltd.
  • 22. Taj Pharmaceuticals Ltd.
  • 23. Taro Pharmaceutical Industries Ltd.
  • 24. Viatris, Inc.
  • 25. Xiromed LLC

LIST OF FIGURES

  • FIGURE 1. ACTINIC KERATOSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACTINIC KERATOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACTINIC KERATOSIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SUBCLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY FLUOROURACIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY IMIQUIMOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY INGENOL MEBUTATE OR DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CURETTAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRIVATE DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SPAS & REJUVENATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023